76 research outputs found
Motion robust MR fingerprinting scan to image neonates with prenatal opioid exposure
Background: A noninvasive and sensitive imaging tool is needed to assess the
fast-evolving baby brain. However, using MRI to study non-sedated babies faces
roadblocks, including high scan failure rates due to subjects motion and the
lack of quantitative measures for assessing potential developmental delays.
This feasibility study explores whether MR Fingerprinting scans can provide
motion-robust and quantitative brain tissue measurements for non-sedated
infants with prenatal opioid exposure, presenting a viable alternative to
clinical MR scans. Assessment: MRF image quality was compared to pediatric MRI
scans using a fully crossed, multiple reader multiple case study. The
quantitative T1 and T2 values were used to assess brain tissue changes between
babies younger than one month and babies between one and two months.
Statistical Tests: Generalized estimating equations (GEE) model was performed
to test the significant difference of the T1 and T2 values from eight white
matter regions of babies under one month and those are older. MRI and MRF image
quality were assessed using Gwets second order auto-correlation coefficient
(AC2) with its confidence levels. We used the Cochran-Mantel-Haenszel test to
assess the difference in proportions between MRF and MRI for all features and
stratified by the type of features. Results: In infants under one month of age,
the T1 and T2 values are significantly higher (p<0.005) compared to those
between one and two months. A multiple-reader and multiple-case study showed
superior image quality ratings in anatomical features from the MRF images than
the MRI images. Conclusions: This study suggested that the MR Fingerprinting
scans offer a motion-robust and efficient method for non-sedated infants,
delivering superior image quality than clinical MRI scans and additionally
providing quantitative measures to assess brain development
Recommended from our members
Selective missing pulse steady state free precession (MP-SSFP): Inner volume and chemical shift selective imaging in a steady state sequence
Recommended from our members
Rapid dark-blood carotid vessel-wall imaging with random bipolar gradients in a radial SSFP acquisition
In Vivo Assessment of Oxygen Consumption via Deuterium Magnetic Resonance
We present a novel approach to simultaneously measure, in vivo, non-invasively, glucose and oxygen consumption via Deuterium Magnetic Resonance (DMR). Mice are administered deuteriated glucose by intravenous injection. The rate of formation of nascent (deuteriated) mitochondrial water is then measured via DMR. The rate of glucose metabolism and oxygen utilization is assessed by tracking their separate peaks in DMR spectra during dynamic scanning. Further studies will aim to validate these results by comparison with in vivo O-17-MRI (mitochondrial function), C-13-MRI and (19)FDG-PET (glucose metabolism) and ex vivo H-1- and H-2-MR, as well as mass spectrometry.(1
Normalized T1 Magnetic Resonance Imaging for Assessment of Regional Lung Function in Adult Cystic Fibrosis Patients - A Cross-Sectional Study
Background: Cystic fibrosis (CF) patients would benefit from a safe and effective tool to detect early-stage, regional lung disease to allow for early intervention. Magnetic Resonance Imaging (MRI) is a safe, non-invasive procedure capable of providing quantitative assessments of disease without ionizing radiation. We developed a rapid normalized T1 MRI technique to detect regional lung disease in early-stage CF patients.
Materials and Methods: Conventional multislice, pulmonary T1 relaxation time maps were obtained for 10 adult CF patients with normal spirometry and 5 healthy non-CF control subjects using a rapid Look-Locker MRI acquisition (5 seconds/imaging slice). Each lung absolute T1 map was separated into six regions of interest (ROI) by manually selecting upper, central, and lower lung regions in the left and right lungs. In order to reduce the effects of subject-to-subject variation, normalized T1 maps were calculated by dividing each pixel in the absolute T1 maps by the mean T1 time in the central lung region. The primary outcome was the differences in mean normalized T1 values in the upper lung regions between CF patients with normal spirometry and healthy volunteers.
Results: Normalized T1 (nT1) maps showed visibly reduced subject-to-subject variation in comparison to conventional absolute T1 maps for healthy volunteers. An ROI analysis showed that the variation in the nT1 values in all regions was <= 2% of the mean. The primary outcome, the mean (SD) of the normalized T1 values in the upper right lung regions, was significantly lower in the CF subjects [.914 (.037)] compared to the upper right lung regions of the healthy subjects [.983 (.003)] [difference of .069 (95% confidence interval .032-.105); p=.001). Similar results were seen in the upper left lung region.
Conclusion: Rapid normalized T1 MRI relaxometry obtained in 5 seconds/imaging slice may be used to detect regional early-stage lung disease in CF patients
Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis.
Nonalcoholic steatohepatitis (NASH) is associated with caspase activation. However, a role for pro-inflammatory caspases or inflammasomes has not been explored in diet-induced liver injury. Our aims were to examine the role of caspase-1 in high fat-induced NASH. C57BL/6 wild-type and caspase 1-knockout (Casp1(-/-)) mice were placed on a 12-week high fat diet. Wild-type mice on the high fat diet increased hepatic expression of pro-caspase-1 and IL-1β. Both wild-type and Casp1(-/-) mice on the high fat diet gained more weight than mice on a control diet. Hepatic steatosis and TG levels were increased in wild-type mice on high fat diet, but were attenuated in the absence of caspase-1. Plasma cholesterol and free fatty acids were elevated in wild-type, but not Casp1(-/-) mice, on high fat diet. ALT levels were elevated in both wild-type and Casp1(-/-) mice on high fat diet compared to control. Hepatic mRNA expression for genes associated with lipogenesis was lower in Casp1(-/-) mice on high fat diet compared to wild-type mice on high fat diet, while genes associated with fatty acid oxidation were not affected by diet or genotype. Hepatic Tnfα and Mcp-1 mRNA expression was increased in wild-type mice on high fat diet, but not in Casp1(-/-) mice on high fat diet. αSMA positive cells, Sirius red staining, and Col1α1 mRNA were increased in wild-type mice on high fat diet compared to control. Deficiency of caspase-1 prevented those increases. In summary, the absence of caspase-1 ameliorates the injurious effects of high fat diet-induced obesity on the liver. Specifically, mice deficient in caspase-1 are protected from high fat-induced hepatic steatosis, inflammation and early fibrogenesis. These data point to the inflammasome as an important therapeutic target for NASH
EB1089, a vitamin D receptor agonist, reduces proliferation and decreases tumor growth rate in a mouse model of hormone-induced mammary cancer
1,25-Dihydroxyvitamin D
3 and several of its analogs, such as EB1089, induce growth arrest and apoptosis of breast cancer cells in culture. EB1089 has also been shown to limit growth of xenografts in nude mice and carcinogen-induced mammary tumors in rats. Coupled with the fact that the vitamin D receptor is highly expressed in a large proportion of breast tumors, these data suggest that it may be a broad spectrum therapeutic target. We utilized a transgenic model of hormone-induced mammary cancer, the LH-overexpressing mouse, to assess, for the first time, the efficacy of EB1089 in a spontaneous tumor model. Similar to human breast cancers, the pre-neoplastic mammary glands and mammary tumors in these mice express high levels of vitamin D receptor. Treatment with EB1089 decreased proliferation of mammary epithelial cells in pre-neoplastic glands by 35%. Moreover, half of hormone-induced mammary tumors treated with EB1089 demonstrated a decreased rate of growth, with a subset of these tumors even regressing, suggesting that 1,25-dihydroxyvitamin D
3 analogs may be effective chemopreventive and chemotherapeutic agents for breast cancer
- …